Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Aon plc 8.3 Amendment

4th Nov 2020 13:22

RNS Number : 2729E
J.P. Morgan Securities LLC
04 November 2020
 

Ap19

 

 

AMENDMENT

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

J.P. Morgan Securities LLC

Company dealt in

AON plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.01 ordinary shares

Date of dealing

2 November 2020

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 7,467,834 3.27

 2,640,209 1.15

(2) Derivatives (other than options)

 2,491,071 1.09

 83,780 0.04

(3) Options and agreements to purchase/sell

 

26,300 0.01

Total

 9,958,905 4.36

 2,750,289 1.20

       

 

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

 

 (Note 5)

Purchase (New Borrow)

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

976,800

 

49

13

13,044

23

149

100

7

14

63

4

2

2

4

2

4

317

2,100

9

1

46

7,000

1,046

2

86

3

3

3,000

3,000

3

67

3,400

2,500

339

77

24

11

 

68

120

98

13

21,270

23

100

149

100

100

200

200

14

14

61

100

100

200

100

200

400

100

22

13

400

317

22

200

700

200

100

2,100

24

25

29

19

33

200

21

200

23

800

9

25

131

46

100

100

254

186

3,000

100

2

100

100

12

52

11

201

195

3

2

4

100

NA

 

180.6000

180.6377

180.6400

180.6404

180.8819

181.0200

181.1300

181.2193

181.2324

181.2750

181.3250

181.3600

181.7250

181.7800

181.7950

182.0214

182.1695

182.4100

182.4200

182.5400

182.6100

182.7692

182.7850

182.9500

182.9533

182.9567

182.9800

182.9925

183.0067

183.1600

183.1775

183.1886

183.4215

183.7700

183.9150

184.0100

 

180.5200

180.5413

180.6000

180.6377

180.6400

180.6404

180.7700

180.8819

180.9400

180.9800

181.0200

181.1300

181.2193

181.2200

181.2216

181.2700

181.2900

181.6750

181.7700

181.8000

181.9825

182.0000

182.0077

182.0081

182.0100

182.0214

182.0695

182.0750

182.1171

182.1300

182.1400

182.1695

182.1788

182.1980

182.2190

182.2342

182.2791

182.2950

182.3048

182.3100

182.3196

182.3300

182.4100

182.4676

182.5000

182.5400

182.7300

182.8200

182.8213

182.9500

182.9925

183.1600

183.2400

183.2500

183.4800

183.9150

183.9500

184.0100

184.1500

184.1921

184.2367

184.3300

184.3350

184.9500

    

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(USD)

(Note 5)

Equity Swap

Long

 

 

 

 

 

Short

13

14

317

1,000

1,100

 

23

3,000

12

180.6377

181.2196

182.0214

182.1174

182.2168

 

180.6404

182.9925

183.9150

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price (USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Selling

119,500

230.00 USD

American

15JAN21

0.50 USD

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, thisshould be stated.

 

None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  Yes

 

Date of disclosure

4 November 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

 

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

26,300

230.00 USD

American

15-Jan-21

 

 

Notes

 

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2. For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEUPGUPGUPUGWC

Related Shares:

Aon Cl A Ord
FTSE 100 Latest
Value8,826.34
Change-7.69